Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Karin Meijboom

Post Doc

UMASS Medical School

Currently I work on gene therapy for diseases of the central nervous system. My main project is on amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. The project is specifically focused on a hexanucleotide repeat mutation found in chromosome 9 open reading frame 72 (C9orf72) that is toxic and causes ALS pathology. I use different strategies to eliminate or silence this toxic repeat, such as gene editing and the use of microRNAs. My other project is on Neurofibromatosis 2 (NF2), a disease that is caused by mutations in the NF2 gene that result in the growth of multiple tumors throughout the central and peripheral nervous systems. For this, I am designing a viral vector that can deliver a functioning copy of the gene